DarioHealth Corp. (DRIO)
DarioHealth Statistics
Share Statistics
DarioHealth has 41.57M shares outstanding. The number of shares has increased by 38.91% in one year.
| Shares Outstanding | 41.57M |
| Shares Change (YoY) | 38.91% |
| Shares Change (QoQ) | 8.86% |
| Owned by Institutions (%) | 19.19% |
| Shares Floating | 30.04M |
| Failed to Deliver (FTD) Shares | 2.09K |
| FTD / Avg. Volume | 0.51% |
Short Selling Information
The latest short interest is 2.7M, so 6.51% of the outstanding shares have been sold short.
| Short Interest | 2.7M |
| Short % of Shares Out | 6.51% |
| Short % of Float | 7.17% |
| Short Ratio (days to cover) | 7.43 |
Valuation Ratios
The PE ratio is 1.29 and the forward PE ratio is -7.47. DarioHealth's PEG ratio is -0.01.
| PE Ratio | 1.29 |
| Forward PE | -7.47 |
| PS Ratio | 1.95 |
| Forward PS | 0.5 |
| PB Ratio | 0.73 |
| P/FCF Ratio | -1.36 |
| PEG Ratio | -0.01 |
Enterprise Valuation
DarioHealth has an Enterprise Value (EV) of 55.24M.
| EV / Sales | 2.04 |
| EV / EBITDA | -0.96 |
| EV / EBIT | -1.43 |
| EV / FCF | -1.43 |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.72 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | -0.52 |
| Debt / FCF | -0.78 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 56.9% and Return on Invested Capital is 0%.
| Return on Equity | 56.9% |
| Return on Assets | 34.47% |
| Return on Invested Capital | 0% |
| Revenue Per Employee | $137.96K |
| Profits Per Employee | $209.09K |
| Employee Count | 196 |
| Asset Turnover | 0.23 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 40.98M |
| Effective Tax Rate | 100% |
Stock Price Statistics
The stock price has increased by -34.78% in the last 52 weeks. The beta is 1.56, so DarioHealth's price volatility has been higher than the market average.
| Beta | 1.56 |
| 52-Week Price Change | -34.78% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 0.85 |
| Relative Strength Index (RSI) | 61.43 |
| Average Volume (20 Days) | 413.8K |
Income Statement
In the last 12 months, DarioHealth had revenue of 27.04M and earned 40.98M in profits. Earnings per share was 0.61.
| Revenue | 27.04M |
| Gross Profit | 13.27M |
| Operating Income | -57.74M |
| Net Income | 40.98M |
| EBITDA | -57.74M |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0.61 |
Balance Sheet
The company has 27.76M in cash and 30.19M in debt, giving a net cash position of -2.43M.
| Cash & Cash Equivalents | 27.76M |
| Total Debt | 30.19M |
| Net Cash | -2.43M |
| Retained Earnings | -390.34M |
| Total Assets | 118.88M |
| Working Capital | 23.89M |
Cash Flow
In the last 12 months, operating cash flow was -38.56M and capital expenditures -138K, giving a free cash flow of -38.7M.
| Operating Cash Flow | -38.56M |
| Capital Expenditures | -138K |
| Free Cash Flow | -38.7M |
| FCF Per Share | -0.58 |
Margins
Gross margin is 49.06%, with operating and profit margins of -213.55% and 151.56%.
| Gross Margin | 49.06% |
| Operating Margin | -213.55% |
| Pretax Margin | 151.56% |
| Profit Margin | 151.56% |
| EBITDA Margin | -213.55% |
| EBIT Margin | -213.55% |
| FCF Margin | -143.12% |
Dividends & Yields
DRIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 77.6% |
| FCF Yield | -73.28% |
Analyst Forecast
The average price target for DRIO is $2, which is 166.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $2 |
| Price Target Difference | 166.7% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Nov 18, 2019. It was a backward split with a ratio of 1:20.
| Last Split Date | Nov 18, 2019 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -5.38 |
| Piotroski F-Score | 3 |